China's Sinopharm says vaccine '79% effective'

Phase 3 trials of a Sinopharm coronavirus vaccine in China have been found to be 79 percent effective, the Chinese pharma giant said Wednesday. It is however lower than rival jabs developed by Pfizer-BioNTech and Moderna. More than one million people have already been vaccinated with unapproved vaccines in China under its emergency use programme.